The pathophysiology of HCV induced B-cell clonal disorders

Autoimmunity Reviews

Volumn 6, Issue 8, 2007, Pages 581-587

  Landau, Dan Avi ^a,b   Saadoun, David ^a,b   Calabrese, Leonard H ^c   Cacoub, Patrice ^a,b  

^a SORBONNE UNIVERSITÉ   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Cryoglobulinemia; Epidemiology; Hepatitis C virus; Lymphoma; Pathophysiology; Treatment

Indexed keywords

B LYMPHOCYTE RECEPTOR; CHEMOKINE RECEPTOR CXCR3; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERLEUKIN 13; INTERLEUKIN 4; INTERLEUKIN 5; LOW DENSITY LIPOPROTEIN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 1ALPHA; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; NONSTRUCTURAL PROTEIN 3; RHEUMATOID FACTOR; TUMOR NECROSIS FACTOR ALPHA; VASCULAR CELL ADHESION MOLECULE 1; VIRUS PROTEIN;

B CELL LYMPHOMA; B LYMPHOCYTE; CELL SURVIVAL; CELLULAR IMMUNITY; CRYOGLOBULINEMIA; HELICOBACTER PYLORI; HEPATITIS C VIRUS; HUMAN; IMMUNOSTIMULATION; LYMPHOCYTE PROLIFERATION; MOUSE; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; NONHODGKIN LYMPHOMA; NONHUMAN; PATHOPHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; REVIEW; VASCULITIS;

B-LYMPHOCYTES; CRYOGLOBULINEMIA; HEPACIVIRUS; HEPATITIS C; HUMANS; LYMPHOMA, NON-HODGKIN;

EID: 34548473323     PISSN: 15689972     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.autrev.2007.03.010     Document Type: Review

References (40)

1. Agnello V. The aetiology of mixed cryoglobulinaemia associated with hepatitis C virus infection. Scand J Immunol 42 (1995) 179-184
2. Vassilopoulos D., and Calabrese L.H. Hepatitis C virus infection and vasculitis: implications of antiviral and immunosuppressive therapies. Arthritis Rheum 46 (2002) 585-597
3. Invernizzi F., Galli M., Serino G., Monti G., Meroni P.L., Granatieri C., et al. Secondary and essential cryoglobulinemias. Frequency, nosological classification, and long-term follow-up. Acta Haematol 70 (1983) 73-82
4. Monti G., Pioltelli P., Saccardo F., Campanini M., Candela M., Cavallero G., et al. Incidence and characteristics of non-Hodgkin lymphomas in a multicenter case file of patients with hepatitis C virus-related symptomatic mixed cryoglobulinemias. Arch Intern Med 165 (2005) 101-105
5. Gisbert J.P., Garcia-Buey L., Pajares J.M., and Moreno-Otero R. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin's lymphoma: systematic review and meta-analysis. Gastroenterology 125 (2003) 1723-1732
6. Matsuo K., Kusano A., Sugumar A., Nakamura S., Tajima K., and Mueller N.E. Effect of hepatitis C virus infection on the risk of non-Hodgkin's lymphoma: a meta-analysis of epidemiological studies. Cancer Sci 95 (2004) 745-752
7. Trejo O., Ramos-Casals M., Lopez-Guillermo A., Garcia-Carrasco M., Yague J., Cervera R., et al. Hematologic malignancies in patients with cryoglobulinemia: association with autoimmune and chronic viral diseases. Semin Arthritis Rheum 33 (2003) 19-28
8. Saadoun D., Resche-Rigon M., Thibault V., Piette J.C., and Cacoub P. Antiviral therapy for hepatitis C virus-associated mixed cryoglobulinemia vasculitis: a long-term follow up study. Arthritis Rheum 54 (2006) 3696-3706
9. Gisbert J.P., Garcia-Buey L., Pajares J.M., and Moreno-Otero R. Systematic review: regression of lymphoproliferative disorders after treatment for hepatitis C infection. Aliment Pharmacol Ther 21 (2005) 653-662
10. Hermine O., Lefrere F., Bronowicki J.P., Mariette X., Jondeau K., Eclache-Saudreau V., et al. Regression of splenic lymphoma with villous lymphocytes after treatment of hepatitis C virus infection. N Engl J Med 347 (2002) 89-94
11. Hu Y.W., Rocheleau L., Larke B., Chui L., Lee B., Ma M., et al. Immunoglobulin mimicry by Hepatitis C virus envelope protein E2. Virology 332 (2005) 538-549
12. Trendelenburg M., Fossati-Jimack L., Cortes-Hernandez J., Turnberg D., Lewis M., Izui S., et al. The role of complement in cryoglobulin-induced immune complex glomerulonephritis. J Immunol 175 (2005) 6909-6914
13. Roccatello D., Isidoro C., Mazzucco G., Mesiti A., Quattrocchio G., Amore A., et al. Role of monocytes in cryoglobulinemia-associated nephritis. Kidney Int 43 (1993) 1150-1155
14. Reininger L., Berney T., Shibata T., Spertini F., Merino R., and Izui S. Cryoglobulinemia induced by a murine IgG3 rheumatoid factor: skin vasculitis and glomerulonephritis arise from distinct pathogenic mechanisms. Proc Natl Acad Sci U S A 87 (1990) 10038-10042
15. Cacoub P., Maisonobe T., Thibault V., Gatel A., Servan J., Musset L., et al. Systemic vasculitis in patients with hepatitis C. J Rheumatol 28 (2001) 109-118
16. Saadoun D., Bieche I., Maisonobe T., Asselah T., Laurendeau I., Piette J.C., et al. Involvement of chemokines and type 1 cytokines in the pathogenesis of hepatitis C virus-associated mixed cryoglobulinemia vasculitis neuropathy. Arthritis Rheum 52 (2005) 2917-2925
17. Kaplanski G., Maisonobe T., Marin V., Gres S., Robitail S., Farnarier C., et al. Vascular cell adhesion molecule-1 (VCAM-1) plays a central role in the pathogenesis of severe forms of vasculitis due to hepatitis C-associated mixed cryoglobulinemia. J Hepatol 42 (2005) 334-340
18. Boyer O., Saadoun D., Abriol J., Dodille M., Piette J.C., Cacoub P., et al. CD4 + CD25 + regulatory T-cell deficiency in patients with hepatitis C-mixed cryoglobulinemia vasculitis. Blood 103 (2004) 3428-3430
19. Cacoub P., Renou C., Kerr G., Hue S., Rosenthal E., Cohen P., et al. Influence of HLA-DR phenotype on the risk of hepatitis C virus-associated mixed cryoglobulinemia. Arthritis Rheum 44 (2001) 2118-2124
20. Charo I.F., and Ransohoff R.M. The many roles of chemokines and chemokine receptors in inflammation. N Engl J Med 354 (2006) 610-621
21. Pileri P., Uematsu Y., Campagnoli S., Galli G., Falugi F., Petracca R., et al. Binding of hepatitis C virus to CD81. Science 282 (1998) 938-941
22. Sakamuro D., Furukawa T., and Takegami T. Hepatitis C virus nonstructural protein NS3 transforms NIH 3T3 cells. J Virol 69 (1995) 3893-3896
23. Ray R.B., Meyer K., and Ray R. Suppression of apoptotic cell death by hepatitis C virus core protein. Virology 226 (1996) 176-182
24. Boisvert J., He X.S., Cheung R., Keeffe E.B., Wright T., and Greenberg H.B. Quantitative analysis of hepatitis C virus in peripheral blood and liver: replication detected only in liver. J Infect Dis 184 (2001) 827-835
25. Kunkel H.G., Agnello V., Joslin F.G., Winchester R.J., and Capra J.D. Cross-idiotypic specificity among monoclonal IgM proteins with anti-globulin activity. J Exp Med 137 (1973) 331-342
26. Marasca R., Vaccari P., Luppi M., Zucchini P., Castelli I., Barozzi P., et al. Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma. Am J Pathol 159 (2001) 253-261
27. Ivanovski M., Silvestri F., Pozzato G., Anand S., Mazzaro C., Burrone O.R., et al. Somatic hypermutation, clonal diversity, and preferential expression of the VH 51p1/VL kv325 immunoglobulin gene combination in hepatitis C virus-associated immunocytomas. Blood 91 (1998) 2433-2442
28. De Re V., De Vita S., Marzotto A., Gloghini A., Pivetta B., Gasparotto D., et al. Pre-malignant and malignant lymphoproliferations in an HCV-infected type II mixed cryoglobulinemic patient are sequential phases of an antigen-driven pathological process. Int J Cancer 87 (2000) 211-216
29. Chan C.H., Hadlock K.G., Foung S.K., and Levy S. V(H)1-69 gene is preferentially used by hepatitis C virus-associated B-cell lymphomas and by normal B-cells responding to the E2 viral antigen. Blood 97 (2001) 1023-1026
30. Quinn E.R., Chan C.H., Hadlock K.G., Foung S.K., Flint M., and Levy S. The B-cell receptor of a hepatitis C virus (HCV)-associated non-Hodgkin lymphoma binds the viral E2 envelope protein, implicating HCV in lymphomagenesis. Blood 98 (2001) 3745-3749
31. De Re V., Sansonno D., Simula M.P., Caggiari L., Gasparotto D., Fabris M., et al. HCV-NS3 and IgG-Fc crossreactive IgM in patients with type II mixed cryoglobulinemia and B-cell clonal proliferations. Leukemia 20 (2006) 1145-1154
32. Zuckerman E., Slobodin G., Kessel A., Sabo E., Yeshurun D., Halas K., et al. Peripheral B-cell CD5 expansion and CD81 overexpression and their association with disease severity and autoimmune markers in chronic hepatitis C virus infection. Clin Exp Immunol 128 (2002) 353-358
33. Cacoub P., Bourliere M., Hausfater P., Charlotte F., Khiri H., Toci S., et al. Lower expression of CD81 B-cell receptor in lymphoproliferative diseases associated with hepatitis C virus infection. J Viral Hepat 10 (2003) 10-15
34. Machida K., Cheng K.T., Pavio N., Sung V.M., and Lai M.M. Hepatitis C virus E2-CD81 interaction induces hypermutation of the immunoglobulin gene in B-cells. J Virol 79 (2005) 8079-8089
35. Wack A., Soldaini E., Tseng C., Nuti S., Klimpel G., and Abrignani S. Binding of the hepatitis C virus envelope protein E2 to CD81 provides a co-stimulatory signal for human T cells. Eur J Immunol 31 (2001) 166-175
36. Realdon S., Pontisso P., Adami F., Trentin L., Noventa F., Ferrari A., et al. High levels of soluble tumor necrosis factor superfamily receptors in patients with hepatitis C virus infection and lymphoproliferative disorders. J Hepatol 34 (2001) 723-729
37. Gross J.A., Johnston J., Mudri S., Enselman R., Dillon S.R., Madden K., et al. TACI and BCMA are receptors for a TNF homologue implicated in B-cell autoimmune disease. Nature 404 (2000) 995-999
38. Sene D., Limal N., Ghillani-Dalbin P., Saadoun D., Piette J.C., and Cacoub P. Hepatitis C virus-associated B-cell proliferation-the role of serum B lymphocyte stimulator (BLyS/BAFF). Rheumatology (Oxford) 46 (2007) 65-69
39. Zuckerman E., Zuckerman T., Sahar D., Streichman S., Attias D., Sabo E., et al. bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 112 (2001) 364-369
40. Zignego A.L., Ferri C., Giannelli F., Giannini C., Caini P., Monti M., et al. Prevalence of bcl-2 rearrangement in patients with hepatitis C virus-related mixed cryoglobulinemia with or without B-cell lymphomas. Ann Intern Med 137 (2002) 571-580